Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuo Shioda

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Uirusu|March 26, 2026
[The history of HIV]Tatsuo Shioda
International Journal of Hematology|July 27, 2006
Human genetic polymorphisms affecting HIV-1 diseasesTatsuo Shioda, Emi E Nakayama
AIDS (London, England)|September 16, 2015
Impact of TRIM5α in vivoEmi E Nakayama, Tatsuo Shioda
Microorganisms|April 28, 2023
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In VivoEmi E Nakayama, Tatsuo Shioda
Pathogens (Basel, Switzerland)|January 8, 2025
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19Emi E Nakayama, Tatsuo Shioda
Uirusu|March 25, 2006
[TRIM5alpha]Emi E Nakayama, Tatsuo Shioda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Host genetic polymorphisms in the pathogenesis of HIV-1 disease]Emi E Nakayama, Tatsuo Shioda
Reviews in Medical Virology|January 6, 2010
Anti-retroviral activity of TRIM5 alphaEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|February 1, 2012
TRIM5α and Species Tropism of HIV/SIVEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|March 22, 2012
Role of Human TRIM5α in Intrinsic ImmunityEmi E Nakayama, Tatsuo Shioda
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Uirusu|March 26, 2026
[The history of HIV]Tatsuo Shioda
International Journal of Hematology|July 27, 2006
Human genetic polymorphisms affecting HIV-1 diseasesTatsuo Shioda, Emi E Nakayama
AIDS (London, England)|September 16, 2015
Impact of TRIM5α in vivoEmi E Nakayama, Tatsuo Shioda
Microorganisms|April 28, 2023
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In VivoEmi E Nakayama, Tatsuo Shioda
Pathogens (Basel, Switzerland)|January 8, 2025
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19Emi E Nakayama, Tatsuo Shioda
Uirusu|March 25, 2006
[TRIM5alpha]Emi E Nakayama, Tatsuo Shioda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[Host genetic polymorphisms in the pathogenesis of HIV-1 disease]Emi E Nakayama, Tatsuo Shioda
Reviews in Medical Virology|January 6, 2010
Anti-retroviral activity of TRIM5 alphaEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|February 1, 2012
TRIM5α and Species Tropism of HIV/SIVEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|March 22, 2012
Role of Human TRIM5α in Intrinsic ImmunityEmi E Nakayama, Tatsuo Shioda
Pageof 16